Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Solve your real-world data problems with support from this valuable network of global institutions.
Work with like-minded groups committed to better data use in areas like rare disease, cancer, and infectious disease.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
4 Mar 2014
The Global Alliance for Genomics and Health (GA4GH), an alliance of over 150 of the world’s leading biomedical research institutions, healthcare providers, information technology and life science companies, funders of research, and disease and patient advocacy organizations, announced progress since the group’s formation and plans for future work at a partner meeting held today at the Wellcome Trust in London.
LONDON, UK (March 4, 2014) –– The Global Alliance for Genomics and Health (GA4GH), an alliance of over 150 of the world’s leading biomedical research institutions, healthcare providers, information technology and life science companies, funders of research, and disease and patient advocacy organizations, announced progress since the group’s formation and plans for future work at a partner meeting held today at the Wellcome Trust in London. The Global Alliance aims to accelerate the worldwide effort to responsibly aggregate and analyze large amounts of genomic and clinical information – seeking best practices where they exist, and developing new approaches where needed – in order to advance the understanding, diagnosis, and treatment for cancer, inherited diseases, infectious diseases, and drug responses.
Almost two hundred of the world’s leading experts in healthcare, biomedical research, technology, ethics, and patient advocacy met today for the first face-to-face GA4GH partner meeting. The key challenge partners addressed is that while a wealth of genome sequence information is set to be gathered, such information becomes interpretable only when compared across many individuals. Yet existing data sets sit in separate silos, with incompatible methods and under complex regulation, creating barriers to such comparison and possible discovery. The meeting focused on coordinating the development of harmonized approaches and interoperable methods to enable learning and make it easier for all to explore the transformational potential of genomic data.
“Just over a year ago, leaders in the field came together to discuss the historic opportunity to utilize the growing wealth of genetic data to benefit humanity, and the growing challenges of data silos and incompatible information that must be overcome to realize this benefit,” said David Altshuler, Chair of the GA4GH Transitional Steering Committee, Deputy Director of the Broad Institute of Harvard and MIT, and a physician at Massachusetts General Hospital. “In a remarkably short time we have progressed from initial conversations to a working alliance made up of over 150 non-profit and for-profit organizations in over 20 countries. Together, we are collaborating to share knowledge and experience, identify and disseminate best practices, and, where needed, develop high-impact, innovative solutions to accelerate progress to benefit medicine and human health.”
The Global Alliance for Genomics and Health aims to enhance sharing and interpretation of genomic and clinical information – and build on existing work, best practices, and approaches – by acting as a global clearinghouse, innovator, catalyst, and hub for data sharing efforts. The group is also focused on protecting patient and participant autonomy and privacy, and partners are working together to promote the highest standards for ethics and to ensure that participants have the choice to responsibly and securely share their genomic and clinical data.
“Since its inception, the Global Alliance has focused on the goal of achieving better data sharing and interoperability to advance science and leverage the positive impact of genomic information on human health,” said Mike Stratton, Director of the Wellcome Trust Sanger Institute. “As part of these important meetings here at the Wellcome Trust, partners are coming together in person to actively discuss ideas and work on products that will lead to a common framework of widely used approaches to advance responsible data sharing and protect privacy.”
Stemming from an initial meeting held in January 2013, last June almost 70 organizations announced their intention to form a global alliance to tackle the challenges of genomic and clinical data sharing. Since then, the inclusive effort has doubled its membership and continued to bring on world-leading organizations from a wide range of critical fields to collaborate on solutions. The Global Alliance for Genomics and Health now has 151 partners, all of whom offer important perspectives and expertise and are pooling their intellectual resources to develop and harmonize approaches to data sharing and enabling discovery. Since its initial formation, the GA4GH has brought on highly- esteemed research and health institutions with broadened international representation, partners from over 20 leading life science and information technology companies, including world leaders in cloud computing, biotechnology, and healthcare generally, and additional respected disease and patient advocacy groups.
“The Global Alliance for Genomics and Health is a key next step in the efforts that began with the Human Genome Project,” said Francis S. Collins, M.D., Ph.D., Director of the National Institutes of Health. “We know that genomic medicine is poised to have a transformative impact, but we still face significant barriers to deploying it effectively. The work of the Global Alliance is intended to break down one of the critical barriers, catalyzing effective, responsible sharing of data sets, in order to benefit science and medicine throughout the world.”
To advance this important work, the Global Alliance for Genomics and Health has convened Working Groups focused on areas critical to enabling effective and responsible data sharing:
The Genomic Data Working Group concentrates on data representation, storage, and analysis of genomic data, including working with academic and industry leaders to develop approaches that facilitate interoperability.
The Security Working Group focuses on ensuring sensitive information is kept secure, including technology aspects of data security, user access control, and audit functions, working to adopt or develop standards for data security, privacy protection, and user/owner access control.
The Regulatory and Ethics Working Group focuses on ethics and the legal and social implications of the Global Alliance, including harmonizing approaches, policies, and standards, and developing forward-looking consent, privacy procedures, and best practices in data governance and transparency.
The Clinical Working Group is working to identify best practices and establish linkages to phenotypic and clinical (health) informatics data. Rather than invent such standards, this Working Group is focusing on aligning genomic data activities with the ongoing international standards initiatives in clinical and health data.
Currently, GA4GH Working Groups are laying the groundwork for genomic and clinical data sharing. For example, to help facilitate the exchange of information, Genomic Data Working Group members have collaborated with leading experts in the public and private sectors to update the current industry-standard file formats for relevant data, and are developing forward-looking machine-readable interfaces (“APIs”) to enable the exchange of variation in genome sequences across groups.
As another example, Regulatory and Ethics Working Group members have begun developing an International Code of Conduct centered on harmonizing approaches around core elements of consent to ensure that patient and participant autonomy and privacy are protected when genomic and clinical data are shared. An extensive survey of existing approaches and ethics guidelines is underway, and the in-person meetings in London produced a framework outline that will be refined and expanded in collaboration with stakeholders across the world.
“The outcomes of the plenary and Working Group meetings and our continued work will help meet the challenge of genomic and clinical data sharing and enable real solutions that break down existing data sharing barriers,” said Kathryn North, Vice Chair of the GA4GH Transitional Steering Committee, Director of the Murdoch Childrens Research Institute, and the David Danks Professor of Child Health Research at the University of Melbourne. “By bringing together leading experts across sectors and giving them the forum to collaborate on innovative solutions, the Global Alliance for Genomics and Health is able to act as a convener and catalyst for data sharing in an inclusive and effective way.”
The Global Alliance for Genomics and Health is an international, non-profit alliance formed to help accelerate the potential of genomic medicine to advance human health. Bringing together over 150 leading institutions working in healthcare, research, disease and patient advocacy, life science, and information technology, partners in the Global Alliance are working together to create a common framework of standards and harmonized approaches to enable the responsible, voluntary, and s